Combinations of substituted 1-phenyl-1,5-dihydro-pyrido- [3,2-B] indol-2-ones and other HIV inhibitors

Details for Australian Patent Application No. 2005244449 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Hertogs, Kurt; Canard, Maxime Francis Jean-Marie Ghislain; Kindermans, Natalie Maria Francisca; De Vroey, Veronique Corine Paul; Bettens, Eva; Tahri, Abdellah; Wigerinck, Piet Tom Bert Paul; Wang, Jing; Van De Vreken, Wim; Jochmans, Dirk Edward Desire; Surleraux, Dominique Louis Nestor Ghislain; Kesteleyn, Bart Rudolf Romanie

Agent Shelston IP

Pub. Number AU-A-2005244449

PCT Pub. Number WO2005/110411

Priority 04102173.4 17.05.04 EP

Filing date 17 May 2005

Wipo publication date 24 November 2005

International Classifications

A61K 31/475 (2006.01) - having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110411 Priority application(s): WO2005/110411

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244450-Medicaments containing Nsulfamoyl-N'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions

2005244448-Hydrogel interferon formulations